Hannah Lui Park

Hannah Lui Park

UNVERIFIED PROFILE

Are you Hannah Lui Park?   Register this Author

Register author
Hannah Lui Park

Hannah Lui Park

Publications by authors named "Hannah Lui Park"

Are you Hannah Lui Park?   Register this Author

27Publications

422Reads

7Profile Views

Effective risk communication to promote behavioral change in patients at elevated risk for breast cancer based on the Health Belief Model.

Breast J 2018 11 6;24(6):1097-1098. Epub 2018 Aug 6.

Department of Epidemiology, School of Medicine, University of California, Irvine, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13086DOI Listing
November 2018

Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.

Clin Breast Cancer 2018 04 10;18(2):e179-e185. Epub 2017 Aug 10.

Department of Epidemiology, University of California, Irvine, School of Medicine, Irvine, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15268209173025
Publisher Site
http://dx.doi.org/10.1016/j.clbc.2017.08.001DOI Listing
April 2018

Beyond Serendipity to an Algorithmic Approach.

Plast Reconstr Surg Glob Open 2018 Feb 6;6(2):e1675. Epub 2018 Feb 6.

VasculoTox, Inc., New York, N.Y.; Department of Plastic Surgery, Kaiser Permanente, Irvine, Calif.; and Department of Epidemiology, University of California Irvine, School of Medicine, Irvine, Calif.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=01720096-201802000-0003
Publisher Site
http://dx.doi.org/10.1097/GOX.0000000000001675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865940PMC
February 2018

Human Nail Clippings as a Source of DNA for Genetic Studies.

Open J Epidemiol 2015 Feb;5(1):41-50

Department of Epidemiology, Genetic Epidemiology Research Institute, University of California, Irvine, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4236/ojepi.2015.51006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499506PMC
February 2015

Prospective analysis of association between statin use and breast cancer risk in the women's health initiative.

Cancer Epidemiol Biomarkers Prev 2013 Oct 23;22(10):1868-76. Epub 2013 Aug 23.

Authors' Affiliations: Weill Cornell Medical College, New York, New York; Wayne State University; Barbara Ann Karmanos Cancer Institute, Detroit, Michigan; Los Angeles Biomedical Research Institute at Harbor, University of California, Los Angeles Medical Center, Los Angeles; University of California, Irvine, Irvine, California; Stony Brook University Medical Center, Stony Brook, New York; Harvard School of Public Health, Boston, Massachusetts; Fred Hutchinson Cancer Research Center, Seattle, Washington; George Washington University, Washington, District of Columbia; NorthShore University Health System, Evanston, Illinois; Albert Einstein College of Medicine, New York; University at Buffalo, The State University of New York, Buffalo, New York; Henry Ford Health Systems, Detroit, Michigan; Lakeland Regional Medical Center, St. Joseph, Michigan; West Virginia University, Morgantown, West Virginia; and University of Tennessee Health Science Center, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0562DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889164PMC
October 2013

Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.

PLoS One 2012 27;7(9):e44951. Epub 2012 Sep 27.

Department of Otolaryngology, Head and Neck Cancer Research Division, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0044951PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459978PMC
March 2013

Pharmacologic unmasking of epigenetically silenced genes in breast cancer.

Clin Cancer Res 2009 Feb;15(4):1184-91

Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082476PMC
February 2009

DCC promoter hypermethylation in esophageal squamous cell carcinoma.

Int J Cancer 2008 Jun;122(11):2498-502

Department of Otolaryngology, Division of Head and Neck Cancer Research, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23434DOI Listing
June 2008

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Mol Cancer Res 2008 Jan;6(1):31-41

Department of Otolaryngology, Head and Neck Cancer Research Division, Johns Hopkins University, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-07-0213DOI Listing
January 2008

Quantitative hypermethylation of NMDAR2B in human gastric cancer.

Int J Cancer 2007 Nov;121(9):1994-2000

Department of Otolaryngology, Division of Head and Neck Cancer Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22934DOI Listing
November 2007

A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.

Clin Cancer Res 2007 Nov;13(22 Pt 1):6658-65

Department of Otolaryngology, Head and Neck Cancer Research Division, Johns Hopkins University, 1550 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1178DOI Listing
November 2007

Alterations of GPI transamidase subunits in head and neck squamous carcinoma.

Mol Cancer 2007 Nov 21;6:74. Epub 2007 Nov 21.

Department of Otolaryngology- Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins Medical Institutions, 601 N. Caroline Street, 6th Floor, Baltimore, MD 21287-0910, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-6-74DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204038PMC
November 2007

A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.

Biochem Biophys Res Commun 2007 Mar 25;354(4):913-8. Epub 2007 Jan 25.

Department of Otolaryngology, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.01.089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1975780PMC
March 2007

Increased plasma DNA integrity index in head and neck cancer patients.

Int J Cancer 2006 Dec;119(11):2673-6

Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins Medical Institutions, Baltimore, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22250DOI Listing
December 2006

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

Cancer Res 2006 Apr;66(7):3409-18

Department of Otolaryngology, Head and Neck Cancer Research Division, Institute of Cell Engineering, Johns Hopkins University School of Medicine, 818 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205-2196, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1608DOI Listing
April 2006

PGP9.5 methylation in diffuse-type gastric cancer.

Cancer Res 2006 Apr;66(7):3921-7

Department of Otolaryngology, Division of Head and Neck Cancer Research, Johns Hopkins University, 720 Rutland Avenue, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1511DOI Listing
April 2006

A novel response element confers p63- and p73-specific activation of the WNT4 promoter.

Biochem Biophys Res Commun 2006 Jan 5;339(4):1120-8. Epub 2005 Dec 5.

Department of Otolaryngology, Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2005.11.118DOI Listing
January 2006

p63-specific activation of the BPAG-1e promoter.

J Invest Dermatol 2005 Jul;125(1):52-60

Department of Otolaryngology, Division of Head and Neck Cancer Research, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0022-202X.2005.23801.xDOI Listing
July 2005

Differential recognition of response elements determines target gene specificity for p53 and p63.

Mol Cell Biol 2005 Jul;25(14):6077-89

Department of Otolaryngology, Division of Head and Neck Surgery, Johns Hopkins University School of Medicine, 818 Ross Research Building, 720 Rutland Avenue, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.25.14.6077-6089.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168821PMC
July 2005

Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype.

Cell Cycle 2004 Dec 7;3(12):1587-96. Epub 2004 Dec 7.

Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.3.12.1290DOI Listing
December 2004